Retatrutide Phase 3: Half of Patients Lost 30% of Body Weight - Eli Lilly's Next GLP-1 Could Rival Bariatric Surgery Pharma, Biotech & Devices CuroNews

Retatrutide Phase 3: Half of Patients Lost 30% of Body Weight - Eli Lilly's Next GLP-1 Could Rival Bariatric Surgery

5 days ago
#Retatrutide #Tirzepatize
Read Article →